Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma: Results from the national cancer database
Main Authors: | A. Martini, J. Pfail, U.G. Falagario, N. Waingankar, G. Gandaglia, N. Fossati, G. Fallara, F. Barletta, S. Scuderi, D. Robesti, D. Cannoletta, A. Necchi, F. Montorsi, A. Briganti, J. Daza, P.J. Treacy, M.D. Galsky, J.P. Sfakianos |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-07-01
|
Series: | European Urology Open Science |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666168320327749 |
Similar Items
-
Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma: results from the national cancer database
by: G. Sorce, et al.
Published: (2020-10-01) -
Predicting toxicity-related Docetaxel discontinuation and survival in metastatic castration-resistant prostate cancer using open phase 3 trial data
by: A. Martini, et al.
Published: (2020-10-01) -
Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trial
by: B. Marco, et al.
Published: (2020-10-01) -
The inverse correlation between obesity and mortality in patients with metastatic castration resistant prostate cancer: Results from the control arms of ASCENT2, MAINSAL and VENICE trials
by: D. Cignoli, et al.
Published: (2020-10-01) -
When to omit lymphadenectomy during radical prostatectomy in patients with clinical localized prostate cancer: A clinical net benefit analysis weighting staging accuracy, risk of morbidity and life expectancy
by: A. Larcher, et al.
Published: (2020-07-01)